Table 1.
Patients characteristics
| Patients N (%) | ||
|---|---|---|
|
| ||
| Age | Mean (range) | 56 (20–77) |
|
| ||
| Gender | Males | 101 (50%) |
| Females | 100 (50%) | |
|
| ||
| Histological type | Thoracic | 35 (17%) |
|
| ||
| Colorectal | 33 (16%) | |
|
| ||
| Breast | 20 (10%) | |
|
| ||
| Mesothelioma | 17 (8%) | |
|
| ||
| Genitourinay (Renal, Bladder, prostate) | 14 (7%) | |
|
| ||
| Melanoma | 10 (5%) | |
|
| ||
| Non-colorectal GI (upper-GI, pancreas) | 17 (8%) | |
|
| ||
| head-and-neck cancer | 8 (4%) | |
|
| ||
| Sarcoma | 8 (4%) | |
|
| ||
| Gynecologic (ovarian, endometrial, cervix) | 10 (5%) | |
|
| ||
| other (thyroid, carcinoma of unknown origin, adrenocortical carcinoma, etc.) | 29 (14%) | |
|
| ||
| Previous lines of chemotherapy (N) | 0 | 21 (10%) |
| 1 | 22 (11%) | |
| 2 | 43 (21%) | |
| 3 | 48 (24%) | |
| 4–8 | 67 (33%) | |
|
| ||
| Number of metastatic sites (N) | 0–1 | 51 (25%) |
| 2 | 87 (43%) | |
| 3 | 52 (26%) | |
| > 4 | 11 (5%) | |
|
| ||
| Royal Marsden Hospital (RMH) prognostic score | 0 | 40 (21%) |
| 1 | 83 (44%) | |
| 2 | 51 (27%) | |
| 3 | 14 (7%) | |